O	0	7	Effects
O	8	10	of
B-intervention	11	19	Exercise
I-intervention	20	23	and
I-intervention	24	41	Cardiorespiratory
I-intervention	42	49	Fitness
O	50	52	on
O	53	61	Estrogen
O	62	72	Metabolism
O	73	75	in
B-eligibility	76	90	Postmenopausal
I-eligibility	91	96	Women
O	96	97	.

O	98	106	Lowering
O	107	117	endogenous
O	118	126	estrogen
O	127	133	levels
O	134	136	is
O	137	140	one
O	141	150	mechanism
O	151	158	whereby
O	159	167	physical
O	168	176	activity
O	177	180	may
O	181	186	lower
O	187	201	postmenopausal
O	202	208	breast
O	209	215	cancer
O	216	220	risk
O	220	221	.

O	222	229	Several
O	230	241	prospective
O	242	249	studies
O	250	254	have
O	255	264	suggested
O	265	269	that
O	270	279	increased
O	280	281	2
O	281	282	-
O	282	295	hydroxylation
O	296	298	of
O	299	308	estrogens
O	309	312	may
O	313	317	also
O	318	324	reduce
O	325	339	postmenopausal
O	340	346	breast
O	347	353	cancer
O	354	358	risk
O	358	359	,
O	360	363	but
O	364	371	whether
O	372	374	or
O	375	378	not
O	379	387	exercise
O	388	394	alters
O	395	403	estrogen
O	404	414	metabolism
O	415	422	through
O	423	427	this
O	428	437	mechanism
O	438	440	is
O	441	448	unclear
O	448	449	.

O	450	452	We
O	453	461	measured
O	462	467	total
O	468	479	circulating
O	480	494	concentrations
O	495	497	of
O	498	504	parent
O	505	514	estrogens
O	515	516	(
O	516	523	estrone
O	524	527	and
O	528	537	estradiol
O	537	538	)
O	539	542	and
O	543	545	13
O	546	554	estrogen
O	555	566	metabolites
O	566	567	,
O	568	577	including
O	578	592	glucuronidated
O	592	593	,
O	594	602	sulfated
O	602	603	,
O	604	607	and
O	608	620	unconjugated
O	621	626	forms
O	626	627	,
O	628	630	by
O	631	637	stable
O	638	645	isotope
O	646	654	dilution
O	655	657	LC
O	657	658	/
O	658	660	MS
O	660	661	-
O	661	663	MS
O	664	666	in
B-intervention-participants	667	670	153
O	671	685	postmenopausal
O	686	691	women
O	692	702	randomized
O	703	705	to
O	706	708	12
O	709	715	months
O	716	718	of
O	719	727	moderate
O	727	728	-
O	728	730	to
O	730	731	-
O	731	739	vigorous
O	740	748	exercise
O	749	752	and
B-control-participants	753	756	153
B-control	757	765	controls
O	765	766	.

O	767	769	We
O	770	774	also
O	775	783	explored
O	784	796	associations
O	797	801	with
O	802	819	cardiorespiratory
O	820	827	fitness
O	828	836	measured
O	837	839	by
O	840	849	treadmill
O	849	850	.

O	851	859	Although
O	860	865	women
O	866	876	randomized
O	877	879	to
O	880	888	exercise
O	889	897	averaged
O	898	901	178
O	902	909	minutes
O	909	910	/
O	910	914	week
O	915	917	of
O	918	926	exercise
O	927	931	over
O	932	934	12
O	935	941	months
O	941	942	,
O	943	948	their
B-outcome	949	966	cardiorespiratory
I-outcome	967	974	fitness
O	975	978	was
O	979	981	13
O	981	982	%
O	983	990	greater
O	991	995	than
O	996	1004	controls
B-outcome	1005	1007	at
I-outcome	1008	1010	12
I-outcome	1011	1017	months
O	1018	1019	(
O	1019	1020	P
O	1021	1022	=
O	1023	1024	0
O	1024	1025	.
O	1025	1029	0001
O	1029	1030	)
O	1030	1031	,
O	1032	1035	and
B-outcome	1036	1041	total
I-outcome	1042	1051	estradiol
O	1052	1055	was
O	1056	1063	reduced
O	1064	1066	by
O	1067	1069	10
O	1069	1070	%
O	1071	1072	(
O	1072	1073	P
O	1074	1075	=
O	1076	1077	0
O	1077	1078	.
O	1078	1080	04
O	1080	1081	)
O	1081	1082	;
O	1083	1088	there
O	1089	1093	were
O	1094	1096	no
O	1097	1110	statistically
O	1111	1122	significant
O	1123	1130	effects
O	1131	1133	of
O	1134	1142	exercise
O	1143	1145	on
B-outcome	1146	1157	circulating
I-outcome	1158	1172	concentrations
I-outcome	1173	1175	of
I-outcome	1176	1184	estrogen
I-outcome	1185	1196	metabolites
O	1197	1199	in
O	1200	1203	the
O	1204	1205	2
O	1205	1206	-
O	1206	1207	,
O	1208	1209	4
O	1209	1210	-
O	1210	1211	,
O	1212	1214	or
O	1215	1217	16
O	1217	1218	-
O	1218	1226	pathways
O	1226	1227	,
O	1228	1230	or
O	1231	1233	on
O	1234	1237	the
O	1238	1239	2
O	1239	1240	-
O	1240	1247	pathway
O	1247	1248	/
O	1248	1254	parent
O	1255	1264	estrogens
O	1265	1270	ratio
O	1270	1271	.

O	1272	1279	However
O	1279	1280	,
O	1281	1283	we
O	1284	1292	observed
O	1293	1294	a
O	1295	1308	statistically
O	1309	1320	significant
B-outcome	1321	1332	association
I-outcome	1333	1340	between
I-outcome	1341	1350	increased
I-outcome	1351	1358	fitness
I-outcome	1359	1362	and
I-outcome	1363	1370	reduced
I-outcome	1371	1384	concentration
I-outcome	1385	1387	of
I-outcome	1388	1389	2
I-outcome	1389	1390	-
I-outcome	1390	1397	pathway
I-outcome	1398	1409	metabolites
O	1410	1411	(
O	1411	1412	P
O	1413	1414	<
O	1415	1416	0
O	1416	1417	.
O	1417	1419	05
O	1419	1420	)
O	1420	1421	.

O	1422	1424	We
O	1425	1430	found
O	1431	1433	no
O	1434	1442	evidence
O	1443	1447	that
O	1448	1450	12
O	1451	1457	months
O	1458	1460	of
O	1461	1469	moderate
O	1469	1470	-
O	1470	1472	to
O	1472	1473	-
O	1473	1481	vigorous
O	1482	1490	exercise
O	1491	1493	or
O	1494	1503	increased
O	1504	1511	fitness
O	1512	1519	changed
O	1520	1528	estrogen
O	1529	1539	metabolism
O	1540	1542	in
O	1543	1544	a
O	1545	1548	way
O	1549	1553	that
O	1554	1559	might
O	1560	1566	reduce
O	1567	1573	breast
O	1574	1580	cancer
O	1581	1585	risk
O	1585	1586	.

O	1587	1590	The
O	1591	1601	protective
O	1602	1608	effect
O	1609	1611	of
O	1612	1620	exercise
O	1621	1623	on
O	1624	1638	postmenopausal
O	1639	1645	breast
O	1646	1652	cancer
O	1653	1655	is
O	1656	1664	unlikely
O	1665	1667	to
O	1668	1670	be
O	1671	1679	mediated
O	1680	1682	by
O	1683	1690	changes
O	1691	1693	in
O	1694	1702	estrogen
O	1703	1713	metabolism
O	1713	1714	.
